Hospira Reports Third-Quarter 20...( -- Reaffirms Earnings ...),Health

-- Reaffirms Earnings Projections for 2007 --

LAKE FOREST, Ill., Nov. 8 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today reported results for the third quarter ended Sept. 30, 2007.

-- Net sales increased 29.6 percent to $838.0 million in the third quarter

of 2007, compared to $646.6 million in the third quarter last year.

Net sales excluding Mayne Pharma sales grew 4.0 percent.

-- Adjusted* third-quarter 2007 diluted earnings per share were $0.49

versus $0.45 in 2006. GAAP third-quarter 2007 diluted earnings per

share were $0.37 versus $0.35 for the same period last year.

"The third quarter was one of solid growth for Hospira's core products and continued progress across the company, and we remain on track to achieve our 2007 earnings projections," said Christopher B. Begley, chairman and chief executive officer. "We're on schedule with our Mayne Pharma integration, and we recently achieved another milestone toward launching our first biogeneric next year in Europe. In advancing our strategies, we are positioning Hospira for sustained future growth."

Third-quarter Financial Highlights

The following table highlights net sales, net income and diluted earnings per share (EPS) results for the quarter ended Sept. 30:

In $ millions, GAAP Adjusted*

except per Three Months Ended Three Months Ended

share amounts Sept. 30, Sept. 30,

---------------- % ---------------- %

2007 2006 Change 2007 2006 Change

--
'/>"/>